# Treatment Evaluation of Neuromodulation for Tinnitus - Stage A2

> **NCT03530306** · NA · COMPLETED · sponsor: **Neuromod Devices Ltd.** · enrollment: 191 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DEVICE:** PS1-PS4
- **DEVICE:** PS6-PS10
- **DEVICE:** PS7-PS4
- **DEVICE:** PS9-PS6

## Key facts

- **NCT ID:** NCT03530306
- **Lead sponsor:** Neuromod Devices Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2018-10-02
- **Final completion:** 2019-07-18
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530306, "Treatment Evaluation of Neuromodulation for Tinnitus - Stage A2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03530306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*